Barron's Research Reports 12-22-2007
3418 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by barrons2
DESCRIPTION:

Date updated:12-22-2007

The following is a list of companies from a collection of various research reports.

symbol name last price % change open
  • +
  • ATU
    Actuant Corp.
  • $13.48
  • 0.00%
  • $13.26

Outperform -- Price 30.75 on Dec. 19 by Baird Securities Maintaining Outperform/36 target on this diversified industrial company. 1Q08 earnings per share were solidly above consensus, and organic growth was slightly ahead of our (and management's) expectations ... we anticipate modest upward revisions to our FY08 estimates. Market-cap: $1.9 billion.

People owning ATU also tend to own: CELGGEGILDMSFTAAPLAGEBP

TheStreet.com Rating: C What is this?

  • +
  • ALVR
    Alvarion Ltd.
  • $3.17
  • +6.38%
  • $3.08

Buy -- Price 9.18 on Dec. 19 by Morgan Joseph ALVR announced another WiMAX deal ... demonstrating it's an established contender in the global mobile-WiMAX market.... Based on quarterly-earnings power of 15 cents, which ALVR could derive in "09, and 25 times earnings multiple [annualized], we target 15. Market-cap: $570 million.

People owning ALVR also tend to own: LUSBLAIRNARTXASVIATWBRY

TheStreet.com Rating: D What is this?

  • +
  • APEI
    American Public E
  • $34.72
  • +4.05%
  • $33.20

Buy -- Price 40 on Dec. 19 by Signal Hill APEI provides online programs focused on military and public-service communities.... Although the shares could prove volatile ... as the model evolves to serve a larger percentage of civilian students, we believe [in] the fundamental strength of the value proposition ... Like Capella, APEI trades better than 30 times our CY09 estimate of $1.33 ... Our CY10 EPS estimate [is] $1.86, suggesting upside of 40% in next 12 months. Market-cap: $707 million.

People owning APEI also tend to own: DUKPPLTIPAAPLCATFCXPFE

TheStreet.com Rating: C- What is this?

  • +
  • KMX
    Carmax Inc.
  • $12.86
  • 0.00%
  • $12.31

Hold -- Price 20.10 on Dec. 19 by Kevin Dann & Partners KMX reported fiscal 3Q08 EPS of 14 cents, versus 21 cents the prior year. CarMax Auto Finance is being negatively affected by unstable credit markets, making it harder for the company to profitably fund receivables through the asset-backed commercial-paper market ... CAF's 3Q08 gain on loans originated and sold declined to 3.6%, versus 4.3% the prior year. Market-cap: $4.38 billion.

People owning KMX also tend to own: EMESWYBIGBTHDLTRECLGGPN

TheStreet.com Rating: C- What is this?

  • +
  • DRRX
    Durect Corporatio
  • $2.66
  • +1.14%
  • $2.60

Buy -- Price 6.82 on Dec. 19 by Merriman Curhan Ford Durect announced positive Phase 2a results for Eladur for ... post-herpetic neuralgia, demonstrating pain control over three days, versus 12 hours for Endo Pharmaceuticals' Lidoderm lidocaine patch. In light of these results -- and the potential for a significant licensing announcement -- we believe investors should continue to aggressively accumulate DRRX [shares] at these levels. Market-cap: $475 million.

People owning DRRX also tend to own: SFETIBXAPTMEPGHGRDKOOLLNUX

TheStreet.com Rating: D What is this?

  • +
  • GS
    Goldman Sachs Gro
  • $143.13
  • 0.00%
  • $143.25

Buy -- Price 208.48 on Dec. 19 by Sandler O'Neill Target: 265. 4Q07 EPS of $7.01 exceeded our $7 and consensus estimate, $6.61... . [Perhaps] some investors were less than impressed with the earnings mix... . But any revenue beat (and 35% return on equity) in such a challenging quarter should be viewed favorably. We believe GS is the best-positioned investment bank to capitalize on growth opportunities ... even in less-than-ideal markets. Market-cap: $91.5 billion.

People owning GS also tend to own: ACEBACCCBCOPCVXDIS

TheStreet.com Rating: C What is this?

  • +
  • MS
    Morgan Stanley
  • $30.09
  • 0.00%
  • $28.27

Sell -- Price 49.84 on Dec. 19 by Punk Ziegel & Co. MS reported F4Q loss of $3.61 a share, ten times greater than projected ... and a reversal of F3Q profit. Earnings estimates for fiscal 2008 and 2009 are being adjusted [to] ... $6.93 and $7.97, respectively [versus] prior estimates, $7.06 and $6.97 per share, respectively. MS reported negative revenues for 4Q and its first quarterly loss in MS history. The negative numbers were the result of a $9.4 billion set of charges and mark-downs in the quarter. It is apparent that the company had a complete breakdown in its risk-management procedures and of its management oversight in its fixed-income division. Market-cap: $49.8 billion.

People owning MS also tend to own: ACEBACCCBCOPCVXDIS

TheStreet.com Rating: D+ What is this?

  • +
  • PRGO
    Perrigo Company
  • $26.73
  • -1.00%
  • $26.72

Outperform/Aggressive Risk -- Price 32.66 on Dec. 19 by Barrington Research Perrigo expects to begin shipping 20-milligram Omeprazole delayed-release tablets (store-brand equivalent to Prilosec OTC) during the calendar 1Q08 or during its fiscal 3Q. Initial annualized sales of the product are expected to be $150 million to $200 million ... We believe PRGO shares can trade at a price/earnings multiple of 25 times, due to PRGO's accelerating growth rate and robust pipeline. New target 42, from 35. Market-cap: $3.09 billion.

People owning PRGO also tend to own: OMNITSCMABMDCBMCLRTEXMILA

TheStreet.com Rating: B- What is this?

previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Cramer's Take on Headline Stocks...

By Rebecca Corvino Posted at 12:47 p.m. EDT on July 6, 2009 Oil was in the red on Monday, sending stocks and the three major indices lower as well. Bank of America (...

07.06.09 | 12:48 PM
Top Tech Short-Squeeze Plays

By Fred Fuld Posted at 12:11 p.m. EDT on July 6, 2009 Revenue and earnings surprises can cause stocks to make sharp moves upwards, which in turn can set off a short sq...

07.06.09 | 12:11 PM
Rocket Stocks for the Week

By Jonas Elmerraji Posted at 11:07 a.m. EDT on July 6, 2009 As we approach the second week in July, the markets have done a good job of matching the summer heat by keep...

07.06.09 | 11:08 AM
Four Must-See Charts: Stem Cell ...

By Stockpickr Staff Posted on July 2, 2009 Developments in the stem cell world are starting to get very interesting. On Tuesday, General Electric (GE) signed an exc...

07.02.09 | 15:19 PM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Will black social ills take a ba...
11.22.08 | 18:53 PM From author Valerie Vecchio
more forums
Q. Scott,What is the stock to buy l...
07.06.09 | 13:29 PM Asked by kjp712

A. MCD and YUM with no doubt in mind. I am
long both.

today 's lists
Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more

TSC Ratings Downgrades

These stocks were downgraded by TheStreet.com Ratings on July 1, 2009. Check out the full article here.... more

Analyst Upgrades

Analyst Upgrades for July 1, 2009. Read more here. more